DE69714230D1 - Neue iridoidderivate und neovaskularisations-inhibitoren die diese als aktviven inhaltstoff enthalten - Google Patents

Neue iridoidderivate und neovaskularisations-inhibitoren die diese als aktviven inhaltstoff enthalten

Info

Publication number
DE69714230D1
DE69714230D1 DE69714230T DE69714230T DE69714230D1 DE 69714230 D1 DE69714230 D1 DE 69714230D1 DE 69714230 T DE69714230 T DE 69714230T DE 69714230 T DE69714230 T DE 69714230T DE 69714230 D1 DE69714230 D1 DE 69714230D1
Authority
DE
Germany
Prior art keywords
vascularization
contain
active ingredients
iridoid derivatives
neovascularization inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69714230T
Other languages
English (en)
Other versions
DE69714230T2 (de
Inventor
Hideaki Morishige
Yukiko Kurita
Yousuke Yamazaki
Chiaki Sakakibara
Masaharu Kigawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tsumura and Co
Original Assignee
Tsumura and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tsumura and Co filed Critical Tsumura and Co
Application granted granted Critical
Publication of DE69714230D1 publication Critical patent/DE69714230D1/de
Publication of DE69714230T2 publication Critical patent/DE69714230T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/94Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems
DE69714230T 1996-03-06 1997-03-05 Neue iridoidderivate und neovaskularisations-inhibitoren die diese als aktviven inhaltstoff enthalten Expired - Fee Related DE69714230T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP7541996 1996-03-06
PCT/JP1997/000675 WO1997032868A1 (fr) 1996-03-06 1997-03-05 Nouveaux derives iridoides et inhibiteurs de la neovascularisation contenant ces derives en tant qu'ingredients actifs

Publications (2)

Publication Number Publication Date
DE69714230D1 true DE69714230D1 (de) 2002-08-29
DE69714230T2 DE69714230T2 (de) 2003-03-27

Family

ID=13575660

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69714230T Expired - Fee Related DE69714230T2 (de) 1996-03-06 1997-03-05 Neue iridoidderivate und neovaskularisations-inhibitoren die diese als aktviven inhaltstoff enthalten

Country Status (9)

Country Link
US (1) US6022888A (de)
EP (1) EP0889041B1 (de)
KR (1) KR19990087526A (de)
AT (1) ATE221073T1 (de)
AU (1) AU717878B2 (de)
CA (1) CA2248725A1 (de)
DE (1) DE69714230T2 (de)
ES (1) ES2180936T3 (de)
WO (1) WO1997032868A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999024439A1 (fr) 1997-11-11 1999-05-20 The Kitasato Institute Nouvelle substance ft-0554 et procede de fabrication
AUPR001000A0 (en) * 2000-09-08 2000-10-05 Biota Scientific Management Pty Ltd Novel chemical compounds and their use
US8790727B2 (en) * 2000-12-05 2014-07-29 Tahitian Noni International, Inc. Morinda citrifolia and iridoid based formulations
US20110217394A1 (en) * 2000-12-05 2011-09-08 Brett Justin West Iridoid Based Formulations
EP1494699A4 (de) * 2002-04-11 2009-07-22 Childrens Medical Center Verfahren zur hemmung der vaskulären hyperpermeabilität
AU2003230852B2 (en) * 2002-04-11 2008-07-10 Children's Medical Center Corporation TNP-470 polymer conjugates and use thereof
WO2004089926A2 (en) 2003-03-31 2004-10-21 Beth Israel Deaconess Medical Center, Inc. Genipin derivatives and uses thereof
US20050222053A1 (en) * 2003-10-31 2005-10-06 Health Research, Inc. Iridoid-saccharide compound and method of using same
US20080032939A1 (en) * 2004-10-28 2008-02-07 Health Research, Inc. Iridoid-saccharide compound and method of using same
WO2006084054A2 (en) * 2005-02-02 2006-08-10 Children's Medical Center Corporation Method of treating angiogenic diseases
JP5142311B2 (ja) * 2006-10-26 2013-02-13 小林製薬株式会社 ゲニポシド酸誘導体
US8642766B2 (en) * 2008-05-05 2014-02-04 Ryan A. Shenvi Synthesis of (+) cortistatin A and related compounds
US20110206786A1 (en) * 2010-02-23 2011-08-25 Brett Justin West Acai and Iridoid Based Formulations
US20120021079A1 (en) * 2010-02-23 2012-01-26 Brett Justin West Garcinia Mangostana L. and Iridoid Based Formulations
US9655999B2 (en) 2013-03-12 2017-05-23 Carnegie Mellon University Coated vaso-occlusive device for treatment of aneurysms
FR3003860B1 (fr) * 2013-03-29 2015-11-27 Oreal Composes derives d'iridoides proteges ou non, composition les comprenant, utilisation comme colorant des fibres keratiniques et dispositifs
CN104892562B (zh) * 2015-06-16 2017-03-15 吴虹 抑制环氧化酶‑2的化合物及其制备方法和应用
CN107400128B (zh) * 2017-07-27 2020-03-31 贵州省中国科学院天然产物化学重点实验室 拟单萜吲哚生物碱及其制备方法和应用
US20220104840A1 (en) 2017-10-16 2022-04-07 Retriever Medical, Inc. Clot Removal Methods and Devices with Multiple Independently Controllable Elements
US10172634B1 (en) 2017-10-16 2019-01-08 Michael Bruce Horowitz Catheter based retrieval device with proximal body having axial freedom of movement
US20220104839A1 (en) 2017-10-16 2022-04-07 Retriever Medical, Inc. Clot Removal Methods and Devices with Multiple Independently Controllable Elements
CN115572278B (zh) * 2022-11-21 2023-09-01 北京志道生物科技有限公司 京尼平衍生物及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1617555C3 (de) * 1966-04-19 1974-09-19 Kali-Chemie Ag, 3000 Hannover Verfahren zur Isolierung von therapeutisch wertvollen Isovaleriansäureestern aus Valeriana- und Kentranthus-Extrakten
US4205083A (en) * 1968-03-30 1980-05-27 Kali-Chemie Aktiengesellschaft Cyclopentapyrans
DE3026579A1 (de) * 1980-07-14 1982-02-11 Kali-Chemie Pharma Gmbh, 3000 Hannover 2,9-dioxatricyclo (4,3,1,o(pfeil hoch)3,7(pfeil hoch)) decane
US4954496A (en) * 1988-08-12 1990-09-04 Fujisawa Pharmaceutical Company, Ltd. Cyclohexane derivatives and pharmaceutical compositions
KR927003493A (ko) * 1990-10-09 1992-12-18 주식회사 쓰무라 이리도이드 유도체 및 그의 의약으로서의 사용
KR100218052B1 (ko) * 1992-07-15 1999-09-01 이병언 B형 간염 바이러스의 복제를 억제하는 약학적 제제

Also Published As

Publication number Publication date
EP0889041A1 (de) 1999-01-07
AU2231797A (en) 1997-09-22
AU717878B2 (en) 2000-04-06
DE69714230T2 (de) 2003-03-27
KR19990087526A (ko) 1999-12-27
CA2248725A1 (en) 1997-09-12
EP0889041A4 (de) 2000-08-23
ATE221073T1 (de) 2002-08-15
ES2180936T3 (es) 2003-02-16
WO1997032868A1 (fr) 1997-09-12
EP0889041B1 (de) 2002-07-24
US6022888A (en) 2000-02-08

Similar Documents

Publication Publication Date Title
DE69714230D1 (de) Neue iridoidderivate und neovaskularisations-inhibitoren die diese als aktviven inhaltstoff enthalten
NO960393L (no) Heterosykliske fenylforbindelser som COX-2-inhibitorer
BR0115411A (pt) Combinações sinergìsticas compreendendo um inibidor de renina para doenças cardiovasculares
ES2182852T3 (es) Derivados de prolinamida.
ATE153855T1 (de) Zusammensetzungen zur behandlung von glaukoma die prostaglandine und clonidinderivate enthalten
IS4695A (is) (Metýlsúlfónýl)fenýl-2-(5H)-fúranón sem sýklóoxýgenasa-2 tálmar
DE69716810T2 (de) 2,3-Disubstituierte-(5,6)-heteroarylkondensierte-pyrimidin-4-one
DE69834500D1 (de) Xanthinderivative zur behandlung von hirnischämie
ATE128459T1 (de) Sulfonanilidderivat und arzneimittel.
DE69029693D1 (de) Hydantoin- oder Imidazolidintrionderivate zur Vorbeugung oder Behandlung von Niereninsuffizienz
BR9503572A (pt) Composto composiçao farmaceutica e método de tratamento ou prevençao de uma doença
BR9608413A (pt) Inibidor de edema cerebral
DK0674515T3 (da) Anvendelse af carbostyrilderivater til fremstilling af et medikament til inhibering af interleukin-8
DE69715173T2 (de) Bisarylcyclobutenderivate als cyclooxygenasehemmer
NO975726D0 (no) N-Hydroksyurea-derivater som anti-inflammatoriske midler
ES2140531T3 (es) Inhibidor de la interleucina-1.
ES2191763T3 (es) Inhibidor del desarrollo de dependencia/tolerancia a un agente analgesico narcotico.
DE69620573T2 (de) Mittel zur verminderung des augeninnendrucks
HN1997000070A (es) Inhibición de las metaloproteinasas de matriz por acidos 2-((1)-aroilalquil) -4-biaril-4-oxoburiticos
DE69327077D1 (de) Carbamoylpyrrolidon-Derivate zur Behandlung von Depressionen und cerebrovasculären Störungen
RU93058386A (ru) Противовирусная комбинация, содержащая неуклеозидный аналог, фармацевтическая композиция, способ лечения
FR2869034B1 (fr) Derive du 14,15-dihydro 20,21-dinoreburnamenin 14-ol et leur utilisation pour le traitement des depressions
DE69428127D1 (de) Schädlingsbekämpfungsmittel

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee